Therapeutic hypothermia for neonates with hypoxic-ischaemic encephalopathy in low- and lower-middle-income countries: a systematic review and meta-analysis
Journal of Tropical Pediatrics · 10.08.2024 · 70 (5)
DOI: 10.1093/tropej/fmae019 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Journal of Tropical Pediatrics, online erschienen am 16.08.2024. Verfasst von Raj Prakash und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neonatology, Northern Care Alliance NHS Trust, Royal Oldham Hospital, Manchester, OL1 2JH, United Kingdom. Hauptthemen laut MEDLINE: Hypothermia, Induced, Hypoxia-Ischemia, Brain, Developing Countries. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 36 Literaturangaben.
Abstract (Originalsprache)
Hypoxic-ischaemic encephalopathy (HIE) is a major cause of mortality and neurodevelopmental disability, especially in low-income countries. While therapeutic hypothermia has been shown to reduce morbidity and mortality in infants with HIE, some clinical trials in low-income countries have reported an increase in the risk of mortality. We conducted a systematic review and meta-analysis of all randomized and quasi-randomized controlled trials conducted in low-income and lower-middle-income countries that compared cooling therapy with standard care for HIE. Our primary outcome was composite of neonatal mortality and neurodevelopmental disability at 6 months or beyond. The review was registered with PROSPERO (CRD42022352728). Our review included 11 randomized controlled trials with 1324 infants with HIE. The composite of death or disability at 6 months or beyond was lower in therapeutic hypothermia group (RR 0.78, 95% CI 0.66–0.92, I2 = 85%). Neonatal mortality rate did not differ significantly between cooling therapy and standard care (RR 0.92, 95% CI 0.76–1.13, I2 = 61%). Additionally, the cooled group exhibited significantly lower rates of neurodevelopmental disability at or beyond 6 months (RR 0.34, 95%CI 0.22–0.52, I2 = 0%). Our analysis found that neonatal mortality rate did not differ between cooled and noncooled infants in low- and lower-middle-income countries. Cooling may have a beneficial effect on neurodevelopmental disability and the composite of death or disability at 6 months or beyond.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neonatology, Northern Care Alliance NHS Trust, Royal Oldham Hospital, Manchester, OL1 2JH, United Kingdom.
- Nuffield Department of Women's and Reproductive Health, University of Oxford, Women's Centre, John Radcliffe Hospital, Oxford, OX3 9DU, United Kingdom.
- Department of Neonatology, National Institute of Perinatology "Isidro Espinosa de los Reyes", Mexico City 11000, Mexico.
- Department of Neonatology, All India Institute of Medical Sciences, Mangalagiri, Andhra Pradesh, 522503, India.
- Department Paediatrics and Obstetrics, University of Connecticut School of Medicine, Farmington, CT 06030, United States.
ORCID-Profile: Raj Prakash
Zitieren
APA
Prakash, R., Verónica Reyes-García, D., Somanath Hansoge, S., & Rosenkrantz, T. S. (2024). Therapeutic hypothermia for neonates with hypoxic-ischaemic encephalopathy in low- and lower-middle-income countries: a systematic review and meta-analysis. Journal of Tropical Pediatrics, 70(5). https://doi.org/10.1093/tropej/fmae019
Vancouver
Prakash R, Verónica Reyes-García D, Somanath Hansoge S, Rosenkrantz TS. Therapeutic hypothermia for neonates with hypoxic-ischaemic encephalopathy in low- and lower-middle-income countries: a systematic review and meta-analysis. Journal of Tropical Pediatrics. 2024;70(5). doi:10.1093/tropej/fmae019
BibTeX
@article{Prakash2024,
author = {Prakash, Raj and Verónica Reyes-García, Diana and Somanath Hansoge, Sanjana and Rosenkrantz, Ted S},
title = {Therapeutic hypothermia for neonates with hypoxic-ischaemic encephalopathy in low- and lower-middle-income countries: a systematic review and meta-analysis},
journal = {Journal of Tropical Pediatrics},
year = {2024},
volume = {70},
number = {5},
doi = {10.1093/tropej/fmae019}
}
EUVIMED